News for Hims & Hers Health, Inc. (HIMS)

Hims & Hers leverages ZAVA's expertise to enter Europe's weight-loss market, boosting growth and profitability. Read what makes HIMS stock a compelling buy.

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $55.25, denoting a -2.83% change from the preceding trading day.

Hims & Hers Health (HIMS) may face challenges in forming a partnership with Eli Lilly due to restrictions on compounded medications. Eli Lilly's CFO recently in

We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on M. V. Cunha’s Substack. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc.

We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on M. V. Cunha’s Substack. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc. (HIMS)’s share was trading at $52.77 as of 5th June. HIMS’s trailing and forward P/E were 77.60 and 86.96 respectively according to Yahoo […]

Whales with a lot of money to spend have taken a noticeably bullish stance on Hims & Hers Health. Looking at options history for Hims & Hers Health HIMS we det...

Hims & Hers stock is on the upswing after the company secured a weight-loss drug partnership. Hims & Hers is acquiring its way into Europe and wants to build more personalized drugs for its telehealth customers. Many companies have failed to disrupt the complicated U.S. healthcare market.

Shares of Hims & Hers have crushed the market over the last year.

In the current session, the stock is trading at $53.36, after a 1.12% spike. Over the past month, Hims & Hers Health Inc. HIMS stock increased by 8.11%, and in ...

Market Analysis by covering: Hims Hers Health Inc. Read 's Market Analysis on Investing.com

Hims & Hers (HIMS) doubles revenue, expands margins, and grows subscribers. Zava acquisition triples market potential, boosting retention. See more here.

Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Hims & Hers (HIMS) has announced its acquisition of Zava, a leading European telehealth platform and online pharmacy boasting over 1.3 million active users. Thi

Market Performance Overview The stock market gained momentum today, maintaining its upward trend despite Elon Musk's criticism of a budget bill, which he clai

Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. And retail traders should know. We noticed this today when the ...

The company stated that the deal is expected to be finalized by mid-year.

Hims & Hers, trading under the ticker HIMS, experienced a significant uptick in its stock price, jumping 17.5%. The shares rose by $9.96, bringing the new price

Hims & Hers (HIMS) is strengthening its European operations through the acquisition of Zava, a digital health platform active in France, the UK, Germany, and Ir

Hims & Hers Health Inc. (HIMS) shares rose nearly 5% to $59.36 in early trading after announcing the acquisition of ZAVA, expanding its digital health services into the UK, Germany, France, and Ireland. ZAVA’s platform, serving 1.3 million customers with 2.3 million consultations in 2024, will help Hims & Hers…